U.S. Oil and Gas Stock News

If you are wondering whether Motorola Solutions at around US$462.63 is still reasonably priced or starting to look stretched, you are asking the right question for a valuation focused review. The stock has seen a 1% decline over the last 7 days, a 10.2% gain over the past month, is up 21.4% year to date, and has returned 12.9% over the past year, which will shape how current investors think about both upside and risk. Recent coverage around Motorola Solutions has focused on its position as a...

Samsara (IOT) is back on investors’ radar after recent share price moves, with the stock showing a mix of short term gains and longer term declines that invite a closer look at fundamentals. See our latest analysis for Samsara. Recent trading has been volatile, with a 7 day share price return of 7.71% and a 30 day share price return of 14.19% contrasting with a 90 day share price decline of 23.02%. The 3 year total shareholder return of 63.64% sits against a 1 year total shareholder return...

Why the CEO change at Constellation Brands (STZ) matters for shareholders Constellation Brands (STZ) is handing the CEO role to Nicholas Fink as the company works through disappointing organic revenue growth, a projected 3.1% sales decline over the next year, and weaker returns on invested capital. See our latest analysis for Constellation Brands. At a share price of $148.32, Constellation Brands has a 30 day share price return of 10.45% decline and a 1 year total shareholder return of 16.20%...

Firefly Aerospace’s Alpha Flight 7 successfully returned the Alpha rocket to orbit after a prior anomaly. The mission delivered a Lockheed Martin payload and validated key Alpha Block II upgrades. The outcome sets up an accelerated Block II upgrade path that is important for future NASA, defense, and commercial missions. This operational milestone is a fresh development for investors tracking Firefly Aerospace, ticker NasdaqGM:FLY. Firefly Aerospace operates in the small and medium launch...

If you are wondering whether Snowflake's current share price still makes sense for long term investors, the key question is how that price lines up with the value of the business. The stock last closed at US$177.25, with returns of a 0.1% decline over 7 days, a 2.9% decline over 30 days, an 18.2% decline year to date and an 18.3% gain over 1 year, which hints at shifting views on both its potential and its risks. Recent headlines around Snowflake have focused on leadership changes and the...

Leggett & Platt (LEG) has been drawing attention after a difficult stretch for the stock, with negative returns over the past month and past 3 months prompting investors to reassess the furniture components maker. See our latest analysis for Leggett & Platt. At a share price of US$10.21, Leggett & Platt has logged a 19.03% 1 month share price decline and a 7.10% year to date share price fall. However, its 1 year total shareholder return of 31.14% contrasts sharply with much weaker 3 and 5...

CAVA Group (NYSE:CAVA) has opened its first Ohio restaurant in Cincinnati, extending its presence in the Midwest. The company is using its Ohio entry as part of a broader regional build out that supports its goal of reaching 500 locations in the near term. CAVA has outlined a long term ambition to operate 1,000 restaurants across the United States by 2032. CAVA Group, trading at $80.35, is using this Midwest push to grow its national footprint and add new markets beyond its existing core...

In recent weeks, Lincoln Educational Services reported fourth-quarter 2025 results that exceeded revenue forecasts, while insiders and a major shareholder, Juniper Investment Company, reduced their holdings through several stock sales. At the same time, the company is preparing a March 19 Investor Day in Nashville to outline its priorities and growth initiatives through 2030, giving investors fresh insight into how management plans to build on the latest performance. Next, we’ll examine...

Harrow (HROW) has been in focus after reporting higher year over year revenue for both Q4 and 2025, outlining 2026 revenue guidance, and advancing its TRIESENCE program into an FDA cleared Phase 3 trial. See our latest analysis for Harrow. Despite the recent earnings beat and TRIESENCE trial update, Harrow’s 30 day share price return of 25.5% and year to date share price return of 28.8% indicate fading short term momentum. However, the five year total shareholder return of about 3.7x points...

Donnelley Financial Solutions (DFIN) shares moved higher after the company reported quarterly revenue growth of 10.4% year on year and exceeded both revenue and EPS estimates, reinforcing investor attention on its compliance and regulatory software services. See our latest analysis for Donnelley Financial Solutions. Despite the positive earnings surprise and a 23.1% rise in the share price since the results were reported, shorter term trading has been choppy. A 9.26% 1 month share price...

Why Cardinal Health’s latest quarter matters for investors Cardinal Health (CAH) recently reported quarterly earnings and guidance that came in ahead of consensus, paired with acquisitions like Solaris Health, new product launches, and a maintained dividend, drawing fresh attention to the stock. See our latest analysis for Cardinal Health. At a share price of US$219.09, Cardinal Health has seen momentum build, with a 10.55% 90 day share price return and a very strong 1 year total shareholder...

Why Phillips Edison (PECO) is on investors’ radar Phillips Edison (PECO) has drawn attention after recent trading, with shares closing at $38.28 and showing mixed short term returns. This has raised questions about how its current valuation lines up with its fundamentals. See our latest analysis for Phillips Edison. While the 1 day and 7 day share price returns for Phillips Edison have been slightly negative, the 90 day share price return of 9.22% and 1 year total shareholder return of 15.26%...

Primerica (NYSE:PRI) President Peter Schneider recently sold 1,800 shares of company stock. The transaction adds to a pattern of insider sales at Primerica, with no insider purchases reported over the past year. The sale comes with the stock last closing at $249.06, drawing attention to management’s trading activity. For a company like Primerica, where many investors pay close attention to management alignment, repeated insider selling can stand out. The stock last closed at $249.06, with...

Lumen Technologies has recently completed the first phase of its turnaround, including divesting legacy assets to AT&T, reducing leverage, and signing new Private Connectivity Fabric fiber deals with hyperscale cloud providers to strengthen its position in high-growth digital networking services. An important angle is Lumen’s bid to become a core “data supply chain” for AI workloads by monetizing its long-haul fiber network and aiming to improve cash flow visibility after years of revenue...

How the CAPTIVATE GO decision fits into the Dianthus story Dianthus Therapeutics (DNTH) reached an early GO decision in its pivotal Phase 3 CAPTIVATE trial for claseprubart in chronic inflammatory demyelinating polyneuropathy, after hitting a predefined responder threshold ahead of schedule. An independent committee confirmed the interim analysis, allowing the company to keep the 300mg every 2 weeks subcutaneous dosing in Part A and move toward refining Part B, while also engaging regulators...

In early March 2026, Lightwave Logic announced a development agreement with Tower Semiconductor to integrate its electro‑optic polymer modulators into Tower’s PH18 silicon photonics platform, aiming to deliver compact, power‑efficient designs for next‑generation AI, data‑center, and high‑performance computing applications. An important aspect of this collaboration is that customers will be able to participate in multiple engineering tapeouts throughout 2026, potentially accelerating...

If you are wondering whether Dynatrace is attractively priced or not, the next few sections will walk through what the numbers are actually saying about the stock. Dynatrace shares last closed at US$38.02, with returns of 3.3% over 30 days, a 10.2% decline year to date and a 19.7% decline over the past year, which may have some investors reassessing both its growth potential and its risk profile. Recent headlines around Dynatrace have focused on its position in observability and application...

In March 2026, Clearway Energy, Inc. received board approval to seek shareholder consent to amend its charter and automatically convert each share of its Class A common stock into one share of Class C common stock, consolidating its public equity into a single share class after the 2026 annual meeting. The move is designed to simplify Clearway’s capital structure by eliminating the less liquid Class A line, potentially improving trading liquidity, broadening the investor base, and better...

In early March 2026, Kimbell Royalty Partners, LP announced that its Board authorized a unit repurchase program of up to US$100,000,000, to be funded by cash on hand, free cash flow, or borrowings under its revolving credit facility, with any repurchased units to be retired and the authorization running through December 31, 2027. This multi-year buyback plan highlights management’s current emphasis on returning capital to unitholders and offers an additional lever for adjusting the...

JPMorgan Chase has restricted lending to private credit providers after marking down some loans in its own portfolio. Following this move, Lazard (NYSE:LAZ) and other major financial firms have limited redemptions for certain funds to manage liquidity. The actions highlight fresh concerns about liquidity and stability across parts of the financial sector. Lazard, trading at $40.68, is being pulled into a wider industry story as investors react to tighter lending conditions and capped fund...

Why Zscaler stock is drawing fresh attention Zscaler (ZS) shares have been under pressure recently, with negative returns over the past month, past 3 months, and year, putting the cloud security company back on many investors’ watchlists. See our latest analysis for Zscaler. At a latest share price of $151.61, Zscaler’s momentum has cooled, with a 30-day share price return of 13.04% and a year-to-date share price return decline of 31.26%, while the 3-year total shareholder return of 40.21%...

U.S. FDA issues a serious warning letter to Novo Nordisk over failures to properly report postmarketing adverse drug events. Regulators cite missed or delayed disclosures of severe outcomes, including stroke and death, tied to certain medications. FDA instructs Novo Nordisk to provide additional corrective actions within 15 business days, signaling heightened scrutiny of its safety reporting processes. For investors watching NYSE:NVO, this warning lands at a time when the stock is trading...

If you are wondering whether Macerich at around US$18.66 is offering real value today, or if the easy gains are already on the table, this article will walk through what the current price actually implies. The stock has seen a 5.8% decline over the last 7 days and a 3.7% decline over 30 days, yet it still shows a 0.8% return year to date and an 18.6% return over 1 year, with a very large 3 year return and a 73.9% return over 5 years. Recent moves in Macerich's share price come against a...

If you are wondering whether GitLab's share price now reflects a fair deal or an overreaction, you are not alone. That is exactly what this article will unpack. GitLab's stock has been under pressure recently, with a 10.1% decline over the last week, a 27.7% decline over the last month, a 36.9% decline year to date, and a 54.3% decline over the past year. These moves have kept GitLab on many investors' watchlists, as the company remains a key name in DevOps and cloud based software...